Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing–remitting multiple sclerosis

The last two decades have seen the introduction of several therapies for multiple sclerosis (MS). These therapies are intended to work at different levels of the disease, typically targeting direct symptom management, brief corticosteroid administration for acute exacerbations, and the regular use o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruggieri, Serena, Tortorella, Carla, Gasperini, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972027/
https://www.ncbi.nlm.nih.gov/pubmed/24707183
http://dx.doi.org/10.2147/TCRM.S53285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972027/
https://www.ncbi.nlm.nih.gov/pubmed/24707183
http://dx.doi.org/10.2147/TCRM.S53285

Ejemplares similares